1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Chill, J.H.
Quadt, S.R.
Levy, R.
Schreiber, G.
Anglister, J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Structure
STRUE6
2005
0969-2126
11
791
802
10.1016/S0969-2126(03)00120-5
12842042
The human type I interferon receptor. NMR structure reveals the molecular basis of ligand binding.
2003
US
Biochemistry
BICHAW
0033
0006-2960
41
3575
3585
10.1021/bi011778f
The human interferon receptor: NMR-based modeling, mapping of the IFN-alpha2 binding site, and observed ligand-induced tightening
2002
10.2210/pdb1n6v/pdb
pdb_00001n6v
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
24323.438
Interferon-alpha/beta receptor beta chain
1
man
polymer
IFNAR2-EC, IFN-alpha-REC, Type I interferon receptor, IFN-R, Interferon alpha/beta receptor- 2
no
no
SYDSPDYTDESCTFKISLRNFRSILSWELKNHSIVPTHYTLLYTIMSKPEDLKVVKNCANTTRSFCDLTDEWRSTHEAYV
TVLEGFSGNTTLFSCSHNFWLAIDMSFEPPEFEIVGFTNHINVMVKFPSIVEEELQFDLSLVIEEQSEGIVKKHKPEIKG
NMSGNFTYIIDKLIPNTNYCVSVYLEHSDEQAVIKSPLKCTLLPPGQESEFS
SYDSPDYTDESCTFKISLRNFRSILSWELKNHSIVPTHYTLLYTIMSKPEDLKVVKNCANTTRSFCDLTDEWRSTHEAYV
TVLEGFSGNTTLFSCSHNFWLAIDMSFEPPEFEIVGFTNHINVMVKFPSIVEEELQFDLSLVIEEQSEGIVKKHKPEIKG
NMSGNFTYIIDKLIPNTNYCVSVYLEHSDEQAVIKSPLKCTLLPPGQESEFS
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
TG1
PLASMID
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2003-07-15
1
1
2008-04-28
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_ref_seq_dif.details
RCSB
Y
RCSB
2002-11-12
REL
REL
All experiments conducted in Shigemi tubes equipped with insert
1
3D_15N-separated_NOESY
HNHA
HNCA
HNCACB
CBCACONH
3D_13C-separated_NOESY
20mM Tris buffer
8
ambient
308
K
20mM Tris buffer
8
ambient
308
K
20mM Tris buffer
8
ambient
305
K
Structure based upon 1947 NOE-derived distance restraints (1066 of which long range), 172 dihedral angle restraints (of which 88 experimental and 84 TALOS-derived), 138 hydrogen-bond restraints and 109 residual dipolar coupling restraints
distance geometry, simulated annealing
1
minimized average structure
0.4mM U-15N IFNAR2-EC; 20mM d-Tris pH 8, 0.02% NaN3
95% H2O/5% D2O
0.35mM U-13C,15N IFNAR2-EC; 20mM d-Tris pH 8, 0.02% NaN3
95% H2O/5% D2O
0.3mM U-13C,15N IFNAR2-EC; 20mM d-Tris pH 8, 0.02% NaN3
99% D2O
Neidig
processing
XwinNMR
3.0
Brunger
structure solution
CNS
1.1
Delaglio
data analysis
NMRPipe
2.1
Brunger
refinement
CNS
1.1
800
Bruker
DRX
500
Bruker
DMX
SER
1
n
1
SER
1
A
TYR
2
n
2
TYR
2
A
ASP
3
n
3
ASP
3
A
SER
4
n
4
SER
4
A
PRO
5
n
5
PRO
5
A
ASP
6
n
6
ASP
6
A
TYR
7
n
7
TYR
7
A
THR
8
n
8
THR
8
A
ASP
9
n
9
ASP
9
A
GLU
10
n
10
GLU
10
A
SER
11
n
11
SER
11
A
CYS
12
n
12
CYS
12
A
THR
13
n
13
THR
13
A
PHE
14
n
14
PHE
14
A
LYS
15
n
15
LYS
15
A
ILE
16
n
16
ILE
16
A
SER
17
n
17
SER
17
A
LEU
18
n
18
LEU
18
A
ARG
19
n
19
ARG
19
A
ASN
20
n
20
ASN
20
A
PHE
21
n
21
PHE
21
A
ARG
22
n
22
ARG
22
A
SER
23
n
23
SER
23
A
ILE
24
n
24
ILE
24
A
LEU
25
n
25
LEU
25
A
SER
26
n
26
SER
26
A
TRP
27
n
27
TRP
27
A
GLU
28
n
28
GLU
28
A
LEU
29
n
29
LEU
29
A
LYS
30
n
30
LYS
30
A
ASN
31
n
31
ASN
31
A
HIS
32
n
32
HIS
32
A
SER
33
n
33
SER
33
A
ILE
34
n
34
ILE
34
A
VAL
35
n
35
VAL
35
A
PRO
36
n
36
PRO
36
A
THR
37
n
37
THR
37
A
HIS
38
n
38
HIS
38
A
TYR
39
n
39
TYR
39
A
THR
40
n
40
THR
40
A
LEU
41
n
41
LEU
41
A
LEU
42
n
42
LEU
42
A
TYR
43
n
43
TYR
43
A
THR
44
n
44
THR
44
A
ILE
45
n
45
ILE
45
A
MET
46
n
46
MET
46
A
SER
47
n
47
SER
47
A
LYS
48
n
48
LYS
48
A
PRO
49
n
49
PRO
49
A
GLU
50
n
50
GLU
50
A
ASP
51
n
51
ASP
51
A
LEU
52
n
52
LEU
52
A
LYS
53
n
53
LYS
53
A
VAL
54
n
54
VAL
54
A
VAL
55
n
55
VAL
55
A
LYS
56
n
56
LYS
56
A
ASN
57
n
57
ASN
57
A
CYS
58
n
58
CYS
58
A
ALA
59
n
59
ALA
59
A
ASN
60
n
60
ASN
60
A
THR
61
n
61
THR
61
A
THR
62
n
62
THR
62
A
ARG
63
n
63
ARG
63
A
SER
64
n
64
SER
64
A
PHE
65
n
65
PHE
65
A
CYS
66
n
66
CYS
66
A
ASP
67
n
67
ASP
67
A
LEU
68
n
68
LEU
68
A
THR
69
n
69
THR
69
A
ASP
70
n
70
ASP
70
A
GLU
71
n
71
GLU
71
A
TRP
72
n
72
TRP
72
A
ARG
73
n
73
ARG
73
A
SER
74
n
74
SER
74
A
THR
75
n
75
THR
75
A
HIS
76
n
76
HIS
76
A
GLU
77
n
77
GLU
77
A
ALA
78
n
78
ALA
78
A
TYR
79
n
79
TYR
79
A
VAL
80
n
80
VAL
80
A
THR
81
n
81
THR
81
A
VAL
82
n
82
VAL
82
A
LEU
83
n
83
LEU
83
A
GLU
84
n
84
GLU
84
A
GLY
85
n
85
GLY
85
A
PHE
86
n
86
PHE
86
A
SER
87
n
87
SER
87
A
GLY
88
n
88
GLY
88
A
ASN
89
n
89
ASN
89
A
THR
90
n
90
THR
90
A
THR
91
n
91
THR
91
A
LEU
92
n
92
LEU
92
A
PHE
93
n
93
PHE
93
A
SER
94
n
94
SER
94
A
CYS
95
n
95
CYS
95
A
SER
96
n
96
SER
96
A
HIS
97
n
97
HIS
97
A
ASN
98
n
98
ASN
98
A
PHE
99
n
99
PHE
99
A
TRP
100
n
100
TRP
100
A
LEU
101
n
101
LEU
101
A
ALA
102
n
102
ALA
102
A
ILE
103
n
103
ILE
103
A
ASP
104
n
104
ASP
104
A
MET
105
n
105
MET
105
A
SER
106
n
106
SER
106
A
PHE
107
n
107
PHE
107
A
GLU
108
n
108
GLU
108
A
PRO
109
n
109
PRO
109
A
PRO
110
n
110
PRO
110
A
GLU
111
n
111
GLU
111
A
PHE
112
n
112
PHE
112
A
GLU
113
n
113
GLU
113
A
ILE
114
n
114
ILE
114
A
VAL
115
n
115
VAL
115
A
GLY
116
n
116
GLY
116
A
PHE
117
n
117
PHE
117
A
THR
118
n
118
THR
118
A
ASN
119
n
119
ASN
119
A
HIS
120
n
120
HIS
120
A
ILE
121
n
121
ILE
121
A
ASN
122
n
122
ASN
122
A
VAL
123
n
123
VAL
123
A
MET
124
n
124
MET
124
A
VAL
125
n
125
VAL
125
A
LYS
126
n
126
LYS
126
A
PHE
127
n
127
PHE
127
A
PRO
128
n
128
PRO
128
A
SER
129
n
129
SER
129
A
ILE
130
n
130
ILE
130
A
VAL
131
n
131
VAL
131
A
GLU
132
n
132
GLU
132
A
GLU
133
n
133
GLU
133
A
GLU
134
n
134
GLU
134
A
LEU
135
n
135
LEU
135
A
GLN
136
n
136
GLN
136
A
PHE
137
n
137
PHE
137
A
ASP
138
n
138
ASP
138
A
LEU
139
n
139
LEU
139
A
SER
140
n
140
SER
140
A
LEU
141
n
141
LEU
141
A
VAL
142
n
142
VAL
142
A
ILE
143
n
143
ILE
143
A
GLU
144
n
144
GLU
144
A
GLU
145
n
145
GLU
145
A
GLN
146
n
146
GLN
146
A
SER
147
n
147
SER
147
A
GLU
148
n
148
GLU
148
A
GLY
149
n
149
GLY
149
A
ILE
150
n
150
ILE
150
A
VAL
151
n
151
VAL
151
A
LYS
152
n
152
LYS
152
A
LYS
153
n
153
LYS
153
A
HIS
154
n
154
HIS
154
A
LYS
155
n
155
LYS
155
A
PRO
156
n
156
PRO
156
A
GLU
157
n
157
GLU
157
A
ILE
158
n
158
ILE
158
A
LYS
159
n
159
LYS
159
A
GLY
160
n
160
GLY
160
A
ASN
161
n
161
ASN
161
A
MET
162
n
162
MET
162
A
SER
163
n
163
SER
163
A
GLY
164
n
164
GLY
164
A
ASN
165
n
165
ASN
165
A
PHE
166
n
166
PHE
166
A
THR
167
n
167
THR
167
A
TYR
168
n
168
TYR
168
A
ILE
169
n
169
ILE
169
A
ILE
170
n
170
ILE
170
A
ASP
171
n
171
ASP
171
A
LYS
172
n
172
LYS
172
A
LEU
173
n
173
LEU
173
A
ILE
174
n
174
ILE
174
A
PRO
175
n
175
PRO
175
A
ASN
176
n
176
ASN
176
A
THR
177
n
177
THR
177
A
ASN
178
n
178
ASN
178
A
TYR
179
n
179
TYR
179
A
CYS
180
n
180
CYS
180
A
VAL
181
n
181
VAL
181
A
SER
182
n
182
SER
182
A
VAL
183
n
183
VAL
183
A
TYR
184
n
184
TYR
184
A
LEU
185
n
185
LEU
185
A
GLU
186
n
186
GLU
186
A
HIS
187
n
187
HIS
187
A
SER
188
n
188
SER
188
A
ASP
189
n
189
ASP
189
A
GLU
190
n
190
GLU
190
A
GLN
191
n
191
GLN
191
A
ALA
192
n
192
ALA
192
A
VAL
193
n
193
VAL
193
A
ILE
194
n
194
ILE
194
A
LYS
195
n
195
LYS
195
A
SER
196
n
196
SER
196
A
PRO
197
n
197
PRO
197
A
LEU
198
n
198
LEU
198
A
LYS
199
n
199
LYS
199
A
CYS
200
n
200
CYS
200
A
THR
201
n
201
THR
201
A
LEU
202
n
202
LEU
202
A
LEU
203
n
203
LEU
203
A
PRO
204
n
204
PRO
204
A
PRO
205
n
205
PRO
205
A
GLY
206
n
206
GLY
206
A
GLN
207
n
207
GLN
207
A
GLU
208
n
208
GLU
208
A
SER
209
n
209
SER
209
A
GLU
210
n
210
GLU
210
A
PHE
211
n
211
PHE
211
A
SER
212
n
212
SER
212
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
LYS
15
A
N
LYS
15
A
O
SER
26
A
O
SER
26
A
N
SER
23
A
N
SER
23
A
O
LEU
68
A
O
LEU
68
A
O
LYS
48
A
O
LYS
48
A
N
ILE
45
A
N
ILE
45
A
N
LEU
42
A
N
LEU
42
A
O
VAL
82
A
O
VAL
82
A
N
SER
87
A
N
SER
87
A
O
THR
90
A
O
THR
90
A
O
LYS
48
A
O
LYS
48
A
N
ILE
45
A
N
ILE
45
A
N
LEU
42
A
N
LEU
42
A
O
VAL
82
A
O
VAL
82
A
N
THR
81
A
N
THR
81
A
O
HIS
97
A
O
HIS
97
A
N
GLU
113
A
N
GLU
113
A
O
MET
124
A
O
MET
124
A
O
ILE
150
A
O
ILE
150
A
N
SER
147
A
N
SER
147
A
N
VAL
142
A
N
VAL
142
A
O
TYR
184
A
O
TYR
184
A
N
VAL
181
A
N
VAL
181
A
O
LYS
199
A
O
LYS
199
1
A
ASP
3
45.55
-169.25
1
A
ASP
6
-69.85
95.65
1
A
TYR
7
-69.89
73.55
1
A
GLU
10
174.19
63.83
1
A
CYS
12
38.40
34.60
1
A
HIS
32
-120.31
-70.34
1
A
SER
33
-100.75
-67.99
1
A
ASP
51
-111.70
55.51
1
A
ASN
57
79.95
-9.29
1
A
ASN
60
13.08
75.49
1
A
LEU
68
-171.49
88.74
1
A
TYR
79
-59.51
88.47
1
A
SER
94
-160.52
94.73
1
A
ALA
102
-39.78
-33.11
1
A
MET
105
28.93
88.43
1
A
GLU
108
-158.53
-59.03
1
A
PRO
110
-33.66
153.50
1
A
ASP
138
-156.83
34.48
1
A
GLN
146
-110.00
68.29
1
A
LYS
159
-69.81
67.20
1
A
MET
162
-93.17
41.48
1
A
ASP
171
-110.69
-165.70
1
A
PRO
175
-38.70
156.17
1
A
ASN
176
64.67
67.96
1
A
SER
188
177.79
39.76
1
A
ALA
192
-95.21
42.71
1
A
PRO
197
-50.21
107.63
1
A
LEU
198
-49.87
174.84
1
A
PRO
204
-55.44
103.23
1
A
GLN
207
-92.27
38.02
1
A
GLU
208
-74.65
-159.65
1
A
SER
209
-56.92
-166.72
minimized average
Average structure of the interferon-binding ectodomain of the human type I interferon receptor
1
N
N
A
LEU
101
A
LEU
101
HELX_P
A
MET
105
A
MET
105
1
1
5
A
VAL
131
A
VAL
131
HELX_P
A
LEU
135
A
LEU
135
5
2
5
disulf
2.033
A
CYS
12
A
SG
CYS
12
1_555
A
CYS
95
A
SG
CYS
95
1_555
disulf
2.032
A
CYS
58
A
SG
CYS
58
1_555
A
CYS
66
A
SG
CYS
66
1_555
disulf
2.035
A
CYS
180
A
SG
CYS
180
1_555
A
CYS
200
A
SG
CYS
200
1_555
IMMUNE SYSTEM
immunoglobulin fold, fibronectin fold, two-domain structure, IMMUNE SYSTEM
INAR2_HUMAN
UNP
1
28
P48551
SYDSPDYTDESCTFKISLRNFRSILSWELKNHSIVPTHYTLLYTIMSKPEDLKVVKNCANTTRSFCDLTDEWRSTHEAYV
TVLEGFSGNTTLFSCSHNFWLAIDMSFEPPEFEIVGFTNHINVMVKFPSIVEEELQFDLSLVIEEQSEGIVKKHKPEIKG
NMSGNFTYIIDKLIPNTNYCVSVYLEHSDEQAVIKSPLKCTLLPPGQESE
28
237
1N6V
1
210
P48551
A
1
1
210
1
cloning artifact
PHE
211
1N6V
A
P48551
UNP
211
1
cloning artifact
SER
212
1N6V
A
P48551
UNP
212
3
4
4
2
4
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
THR
13
A
THR
13
A
LEU
18
A
LEU
18
A
SER
23
A
SER
23
A
GLU
28
A
GLU
28
A
CYS
66
A
CYS
66
A
LEU
68
A
LEU
68
A
LYS
48
A
LYS
48
A
VAL
54
A
VAL
54
A
TYR
39
A
TYR
39
A
ILE
45
A
ILE
45
A
ALA
78
A
ALA
78
A
SER
87
A
SER
87
A
THR
90
A
THR
90
A
THR
91
A
THR
91
A
LYS
48
A
LYS
48
A
VAL
54
A
VAL
54
A
TYR
39
A
TYR
39
A
ILE
45
A
ILE
45
A
ALA
78
A
ALA
78
A
SER
87
A
SER
87
A
CYS
95
A
CYS
95
A
TRP
100
A
TRP
100
A
GLU
111
A
GLU
111
A
PHE
117
A
PHE
117
A
HIS
120
A
HIS
120
A
LYS
126
A
LYS
126
A
ILE
150
A
ILE
150
A
HIS
154
A
HIS
154
A
SER
140
A
SER
140
A
SER
147
A
SER
147
A
TYR
179
A
TYR
179
A
GLU
186
A
GLU
186
A
LYS
199
A
LYS
199
A
THR
201
A
THR
201